STEK vs XPEL
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STEK is a Hold and XPEL is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
STEK’s FA Score shows that 0 FA rating(s) are green whileXPEL’s FA Score has 0 green FA rating(s).
- STEK’s FA Score: 0 green, 5 red.
- XPEL’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
STEK’s TA Score shows that 4 TA indicator(s) are bullish while XPEL’s TA Score has 5 bullish TA indicator(s).
- STEK’s TA Score: 4 bullish, 5 bearish.
- XPEL’s TA Score: 5 bullish, 3 bearish.
Price Growth
STEK (@Pharmaceuticals: Other) experienced а +0.20% price change this week, while XPEL (@Auto Parts: OEM) price change was +6.23% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +5.53%. For the same industry, the average monthly price growth was -0.55%, and the average quarterly price growth was -7.74%.
The average weekly price growth across all stocks in the @Auto Parts: OEM industry was +4.15%. For the same industry, the average monthly price growth was -6.47%, and the average quarterly price growth was -1.49%.
Reported Earning Dates
STEK is expected to report earnings on Apr 17, 2023.
XPEL is expected to report earnings on Aug 06, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (+5.53% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Auto Parts: OEM (+4.15% weekly)OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.
| STEK | XPEL | STEK / XPEL | |
| Capitalization | 2.98M | 1.54B | 0% |
| EBITDA | -4.36M | 76.9M | -6% |
| Gain YTD | -47.084 | -31.272 | 151% |
| P/E Ratio | 1.05 | 29.22 | 4% |
| Revenue | 4.54M | 396M | 1% |
| Total Cash | 343K | 11.6M | 3% |
| Total Debt | 1.15M | 36.1M | 3% |
STEK | XPEL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 63 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 99 | 76 | |
SMR RATING 1..100 | 94 | 41 | |
PRICE GROWTH RATING 1..100 | 94 | 90 | |
P/E GROWTH RATING 1..100 | 92 | 90 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
STEK's Valuation (50) in the null industry is in the same range as XPEL (50). This means that STEK’s stock grew similarly to XPEL’s over the last 12 months.
XPEL's Profit vs Risk Rating (76) in the null industry is in the same range as STEK (99). This means that XPEL’s stock grew similarly to STEK’s over the last 12 months.
XPEL's SMR Rating (41) in the null industry is somewhat better than the same rating for STEK (94). This means that XPEL’s stock grew somewhat faster than STEK’s over the last 12 months.
XPEL's Price Growth Rating (90) in the null industry is in the same range as STEK (94). This means that XPEL’s stock grew similarly to STEK’s over the last 12 months.
XPEL's P/E Growth Rating (90) in the null industry is in the same range as STEK (92). This means that XPEL’s stock grew similarly to STEK’s over the last 12 months.
| STEK | XPEL | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 90% | 3 days ago 73% |
| Stochastic ODDS (%) | 3 days ago 84% | 3 days ago 81% |
| Momentum ODDS (%) | 6 days ago 90% | 3 days ago 73% |
| MACD ODDS (%) | 5 days ago 88% | 3 days ago 76% |
| TrendWeek ODDS (%) | 3 days ago 83% | 3 days ago 74% |
| TrendMonth ODDS (%) | 3 days ago 87% | 3 days ago 76% |
| Advances ODDS (%) | 3 days ago 78% | 3 days ago 78% |
| Declines ODDS (%) | 5 days ago 90% | 11 days ago 83% |
| BollingerBands ODDS (%) | 3 days ago 84% | 3 days ago 79% |
| Aroon ODDS (%) | 3 days ago 87% | 3 days ago 81% |
STEK and
Correlation & Price change
A.I.dvisor tells us that STEK and CNADF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STEK and CNADF's prices will move in lockstep.
| Ticker / NAME | Correlation To STEK | 1D Price Change % | ||
|---|---|---|---|---|
| STEK | 100% | +0.62% | ||
| CNADF - STEK | 25% Poorly correlated | N/A | ||
| BFRI - STEK | 12% Poorly correlated | -2.35% | ||
| HLNCF - STEK | 11% Poorly correlated | -0.40% | ||
| PLSH - STEK | 8% Poorly correlated | N/A | ||
| EAPIF - STEK | 6% Poorly correlated | N/A | ||
More | ||||
XPEL and
Correlation & Price change
A.I.dvisor indicates that over the last year, XPEL has been loosely correlated with AXL. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if XPEL jumps, then AXL could also see price increases.
| Ticker / NAME | Correlation To XPEL | 1D Price Change % | ||
|---|---|---|---|---|
| XPEL | 100% | +0.18% | ||
| AXL - XPEL | 36% Loosely correlated | +0.81% | ||
| FOXF - XPEL | 33% Poorly correlated | -0.28% | ||
| VC - XPEL | 32% Poorly correlated | +1.24% | ||
| THRM - XPEL | 32% Poorly correlated | N/A | ||
| DAN - XPEL | 32% Poorly correlated | +4.23% | ||
More | ||||